Thiotepa — 15 mg/1.5 mL, Lyophilized powder for solution for injection, 1 × 1.5 mL vial in 1 box, unit-dose — Hikma Pharmaceuticals USA Inc. — NDC 0143-9565-01

Thiotepa — 15 mg/1.5 mL, Lyophilized powder for solution for injection, 1 × 1.5 mL vial in 1 box, unit-dose — Hikma Pharmaceuticals USA Inc. — NDC 0143-9565-01

Thiotepa is a lyophilized powder for solution for injection for intracavitary, intravenous, intravesical use. Thiotepa for Injection, USP has been tried with varying results in the palliation of a wide variety of neoplastic diseases. Supplied as 1 × 1.5 mL vial in 1 box, unit-dose; NDC 0143-9565-01; manufacturer Hikma Pharmaceuticals USA Inc. Rx only. Store in a refrigerator between 2° to 8°C (36° to 46°F). PROTECT FROM LIGHT AT ALL TIMES.

• Active ingredient or product type: THIOTEPA
• Strength/concentration: 15 mg/1.5 mL
• Dosage form and route: Lyophilized powder for solution for injection, Intracavitary, Intravenous, Intravesical
• Exact package presentation: 1 × 1.5 mL vial in 1 box, unit-dose
• NDC/item number: 0143-9565-01
• Manufacturer/labeler: Hikma Pharmaceuticals USA Inc.
• Storage/handling: Store in a refrigerator between 2° to 8°C (36° to 46°F). PROTECT FROM LIGHT AT ALL TIMES.
• Status: Rx only

Important safety information: Review the current product labeling for product-specific contraindications, warnings, and precautions before use.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.